Industry News

NIH Awards USD 1.6 Million Grant to Subtle Medical

By Medimaging International staff writers
03 Oct 2019

Image: Subtle Medical’s AI product SubtleGAD reduces the gadolinium needed during MRI exams without sacrificing diagnostic quality (Photo courtesy of iStock).The National Institutes of Health {(NIH) Bethesda, MA, USA} has awarded healthcare technology company Subtle Medical (Menlo Park, CA, USA) a Fast-Track Small Business Innovation Research (SBIR) grant of USD 1.6 million. The 2.5-year fast track to Phase 2 award will fund an artificial intelligence (AI) product, SubtleGAD, in development by Subtle Medical aimed at reducing gadolinium dosage needed during MRI exams using deep learning (DL). The work will lead to safer contrast-enhanced MRI.

Over 40 million MRI scans are performed annually. Gadolinium-based contrast agents (GBCAs) are used in approximately one-third of all MRI scans. The usage of GBCAs has been linked to the development of nephrogenic systemic fibrosis (NSF). NSF can be painful, cause severe disability, and even death. The recent identification of gadolinium deposition within the brain and body has raised additional safety concerns about the usage of GBCAs. The FDA recently issued warnings about gadolinium retention following contrast-enhanced MRI and required GBCA manufacturers to conduct human and animal studies to further assess the safety of these contrast agents.

Subtle Medical, a healthcare technology company out of Stanford University, has developed a suite of deep learning solutions that enable centers to increase medical imaging speed, improve patient experience and reduce cost. Subtle's first product, SubtlePET, is the first FDA-cleared and CE-marked AI solution for medical imaging enhancement, enabling centers to enhance images from up to 4x faster PET scans. Subtle's second product, SubtleMR, currently under FDA review, was developed with the aim of faster MRI exams. SubtleGAD is the third product under development in Subtle Medical's growing portfolio of new AI technologies. The low-dose contrast-enhanced MRI method will benefit not only millions of patients with advanced chronic kidney disease (CKD) who cannot currently undergo contrast-enhanced MRI, but many more patients with normal kidney function, who are at the risk of gadolinium retention after a contrast-enhanced MRI.

"With SubtleGAD technology, hospitals and imaging centers will be able to deliver safer MRI exams without sacrificing the clinical quality of the images," said Enhao Gong, PhD, Co-founder & CEO of Subtle Medical. "We are grateful to receive NIH's support to further the development of our AI product and bring it into clinical use."

Related Links:
National Institutes of Health
Subtle Medical



E-mail Print
FaceBook Twitter Google+ Linked in

Additional news

25 Nov 2019
LANDAUER and RaySafe Exhibit New Products and Services at RSNA 2019
 LANDAUER (Glenwood, IL, USA) and RaySafe (Billdal, Sweden) showcased several new products and services at the Radiological Society of North America (RSNA) 2019 Annual Meeting held on December 1-5 at McCormick Place in Chicago, USA.
Read More
07 Nov 2019
Global Automated Breast Ultrasound Systems Market to Surpass USD 1.8 Billion by 2025
The global automated breast ultrasound systems (ABUS) market was valued at over USD 0.68 billion in 2018 and is projected to grow at a CAGR 16.1% during the forecast period, 2019-2025 to surpass USD 1.8 billion by 2025, driven by increasing government expenditure and rising awareness about breast cancer. Initiatives such as free check-up camps and symposiums for raising awareness regarding early detection and diagnosis of breast cancer will lead to greater adoption of ABUS in the coming years. However, stringent regulations and guidelines for the approval of ABUS, coupled with the high cost of diagnostic procedure, could hamper the market growth during the forecast period.
Read More
07 Nov 2019
CT System Receives FDA Clearance for AI-Based Image Reconstruction Technology
Canon Medical Systems USA, Inc. (Tustin, CA, USA; www.us.medical.canon) has received 510(k) clearance for its Advanced Intelligent Clear-IQ Engine (AiCE) for the Aquilion Precision, further expanding access to its new deep convolutional neural network (DCNN) image reconstruction technology. The technology, which is now available on Canon’s Aquilion Precision and Aquilion ONE/GENESIS Edition CT systems, uses a deep learning algorithm to differentiate signal from noise so that it can suppress noise while enhancing signal, thus improving CT image reconstruction.
Read More
07 Nov 2019
AI-Powered MRI Image Enhancement Software Receives FDA Clearance
A new image processing software that utilizes proprietary deep learning algorithms to bring the latest imaging enhancement technology to existing scanners has received 510(k) clearance from the US Food and Drug Administration (FDA). The software named SubtleMR uses denoising and resolution enhancement to improve image quality and has been developed by Subtle Medical (Menlo Park, CA, USA; www.subtlemedical.com), a healthcare technology company focused on improving the quality, efficiency, and accessibility of medical imaging.
Read More
06 Nov 2019
UCSF Launches Artificial Intelligence Center to Advance Medical Imaging
The University of California San Francisco {(UCSF) San Francisco, CA, USA; www.ucsf.edu} has announced the launch of a new center to accelerate the application of artificial intelligence (AI) technology to radiology, leveraging advanced computational techniques and industry collaborations to improve patient diagnoses and care. The Center for Intelligent Imaging, or ci2, will develop and apply AI to devise powerful new ways to look inside the body and to evaluate health and disease. The center aims to enable transformation via intelligent radiology, with the goal of again collaborating with the industry to become of the first institutions to bring medical imaging AI to the bedside.
Read More
06 Nov 2019
Global Blood Gas and Electrolyte Analyzers Market to Surpass USD 2.1 Billion by 2025
The global blood gas and electrolyte analyzers market is projected to grow at a CAGR of 6.5% during the forecast period, 2018-2025 to reach a value of over USD 2.1 billion by 2025, driven mainly by the Bench Top segment which is anticipated to bring in healthy gains and add significant momentum to the market growth. The Bench Top segment is projected to grow at a CAGR of over 6.4% during the forecast period.
Read More
06 Nov 2019
AI-Powered Diagnostics Software Guides Cardiologists during Angiography
Researchers are in the initial stages of a pivotal multi-center clinical trial to demonstrate the efficacy of AutocathFFR, a fully automated system that detects stenoses (narrowing) in the coronary arteries surrounding the heart. AutocathFFR provides cardiologists with the relevant physiological parameters that can help them in assessing the severity of their patients' condition and devise the optimal treatment strategy.
Read More
06 Nov 2019
IoT-Enabled Healthcare Equipment Market Projected to Reach USD 69.7 Billion by 2023
The global IoT-enabled healthcare equipment market is projected to grow at the rate of 29.9% annually from USD 18.8 billion in 2018 to USD 69.7 billion in 2023, driven by digitization during the forecast period. Medical devices companies are transforming from device or consumable providers to disease and care management organizations. Digitization in acute or chronic care is greatly aided by IoT-enabled medical devices, such as subcutaneous drug delivery units, continuous glucose monitors and vitals monitoring equipment. The emergence of digital enterprises such as Google and Apple in the consumer health space has led to development of new opportunities and innovations for medical devices companies.
Read More
05 Nov 2019
AI-Driven Software Uses CT Scans to Determine Extent of Brain Injury in Stroke Patients
A new study has shown that an artificial intelligence (AI) driven software can reliably tell doctors how much brain is injured in stroke patients using universally available CT scans, without the need for more complex advanced imaging.
Read More
Copyright © 2000-2019 TradeMed.com. All rights reserved. | Terms And Conditions